These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10136285)

  • 21. Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.
    Kemmeren JM; Timmer SS; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(26):4373-7. PubMed ID: 21514347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
    Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
    JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
    Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N;
    N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964.
    Griffith AH
    Br Med J; 1978 Apr; 1(6116):809-15. PubMed ID: 205305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-vaccination symptoms following DTP and DT vaccination.
    Pollock TM; Miller E; Mortimer JY; Smith G
    Dev Biol Stand; 1985; 61():407-10. PubMed ID: 3879685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
    Langue J; Matisse N; Pacoret P; Undreiner F; Boisnard F; Soubeyrand B;
    Vaccine; 2004 Mar; 22(11-12):1406-14. PubMed ID: 15063563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The possible adjuvant role of bordetella pertussis and pertussis vaccine in causing severe encephalopathic illness: a presentation of three case histories.
    Cavanagh NP; Brett EM; Marshall WC; Wilson J
    Neuropediatrics; 1981 Nov; 12(4):374-81. PubMed ID: 6278350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse events following immunisation: Prospective cohort study evaluating Australian children presenting to specialist immunisation clinics.
    Stubbs H; Palasanthiran P; Koirala A; Lee A; Duguid RC; Brogan D; Wood N; Kandasamy R
    Vaccine; 2024 Apr; 42(10):2661-2671. PubMed ID: 38490823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
    Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran.
    Esteghamati A; Keshtkar A; Heshmat R; Gouya MM; Salar Amoli M; Armin S; Mahoney F
    Arch Iran Med; 2011 Mar; 14(2):91-5. PubMed ID: 21361714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study.
    Gale JL; Thapa PB; Wassilak SG; Bobo JK; Mendelman PM; Foy HM
    JAMA; 1994 Jan; 271(1):37-41. PubMed ID: 7903109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increase in localised symptoms in 4-year-olds following revaccination with DaPT-IPV].
    David S; Vermeer-de Bondt P; van der Maas N
    Ned Tijdschr Geneeskd; 2010; 154():A980. PubMed ID: 20456777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.
    Bults M; Kemmeren JM; van der Maas NA
    Vaccine; 2007 Jul; 25(29):5272-7. PubMed ID: 17573165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy].
    van Wijngaarden JK; Huisman J; van der Meer JW; Visser HK
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2297-301. PubMed ID: 11143295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.